Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, announced today that Amparo de la Peña , Vice President of Pharmacometrics, has been elected to the International Society of Pharmacometrics (ISoP) Board of Trustees.

“Amparo is an experienced pharmacometrician, having spent more than 20 years working for Eli Lilly and Company before going into consulting and serving small biotechs and big pharma companies in diverse therapeutic areas. Throughout her career, she has always sought ways to volunteer and support the growth of our discipline and the careers of junior scientists just starting out,” said Jill Fiedler-Kelly , President of Clinical Pharmacology & Pharmacometrics at Simulations Plus. “In this leadership role, I know Amparo will help extend the influence and impact of ISoP throughout our global industry.”

Three other Trustees were elected to the Board: Jeff Sachs, a Distinguished Scientist at Merck; Pavan Vaddady, Sr. Director & Head of Pharmacometrics, Quantitative Clinical Pharmacology at Daiichi Sankyo, Inc.; and Hao Zhu, Division Director of Pharmacometrics, Office of Clinical Pharmacology at FDA.

“We were fortunate to have so many distinguished candidates whose visionary ideas about how to grow ISoP were inspiring,” said Jennifer Pastore Monroy, Executive Director of ISoP. “We are excited for the energy, enthusiasm, and perspectives [our new Trustees] will bring to the Board.”

The newly elected Trustees will assume their roles effective January 1, 2024.